Literature DB >> 24335532

Glial and neuronal tau pathology in tauopathies: characterization of disease-specific phenotypes and tau pathology progression.

Isidre Ferrer1, Irene López-González, Margarita Carmona, Laura Arregui, Esther Dalfó, Benjamin Torrejón-Escribano, Roberta Diehl, Gabor G Kovacs.   

Abstract

Tauopathies are degenerative diseases characterized by the accumulation of phosphorylated tau in neurons and glial cells. With some exceptions, tau deposits in neurons are mainly manifested as pretangles and tangles unrelated to the tauopathy. It is thought that abnormal tau deposition in neurons occurs following specific steps, but little is known about the progression of tau pathology in glial cells in tauopathies. We compared tau pathology in different astrocyte phenotypes and oligodendroglial inclusions with that in neurons in a large series of tauopathies, including progressive supranuclear palsy, corticobasal degeneration, argyrophilic grain disease, Pick disease, frontotemporal lobar degenerations (FTLD) associated with mutations in the tau gene, globular glial tauopathy (GGT), and tauopathy in the elderly. Our findings indicate that disease-specific astroglial phenotypes depend on i) the primary amino acid sequence of tau (mutated tau, 3Rtau, and 4Rtau); ii) phospho-specific sites of tau phosphorylation, tau conformation, tau truncation, and ubiquitination in that order (which parallel tau modifications related to pretangle and tangle stages in neurons); and iii) modifications of the astroglial cytoskeleton. In contrast to astrocytes, coiled bodies in oligodendrocytes have similar characteristics whatever the tauopathy, except glial globular inclusions in GGT, and coiled bodies and globular oligodendroglial inclusions in FTLD-tau/K317M. These observations indicate that tau pathology in glial cells largely parallels, but is not identical to, that in neurons in many tauopathies.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24335532     DOI: 10.1097/NEN.0000000000000030

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  81 in total

1.  Non-aggregating tau phosphorylation by cyclin-dependent kinase 5 contributes to motor neuron degeneration in spinal muscular atrophy.

Authors:  Nimrod Miller; Zhihua Feng; Brittany M Edens; Ben Yang; Han Shi; Christie C Sze; Benjamin Taige Hong; Susan C Su; Jorge A Cantu; Jacek Topczewski; Thomas O Crawford; Chien-Ping Ko; Charlotte J Sumner; Long Ma; Yong-Chao Ma
Journal:  J Neurosci       Date:  2015-04-15       Impact factor: 6.167

2.  Cerebrovascular inflammation is associated with tau pathology in Guam parkinsonism dementia.

Authors:  Petra Majerova; Ralph M Garruto; Andrej Kovac
Journal:  J Neural Transm (Vienna)       Date:  2018-04-26       Impact factor: 3.575

3.  A novel tau mutation, p.K317N, causes globular glial tauopathy.

Authors:  Pawel Tacik; Michael DeTure; Wen-Lang Lin; Monica Sanchez Contreras; Aleksandra Wojtas; Kelly M Hinkle; Shinsuke Fujioka; Matthew C Baker; Ronald L Walton; Yari Carlomagno; Patricia H Brown; Audrey J Strongosky; Naomi Kouri; Melissa E Murray; Leonard Petrucelli; Keith A Josephs; Rosa Rademakers; Owen A Ross; Zbigniew K Wszolek; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2015-04-22       Impact factor: 17.088

Review 4.  Protein astrogliopathies in human neurodegenerative diseases and aging.

Authors:  Gabor G Kovacs; Virginia M Lee; John Q Trojanowski
Journal:  Brain Pathol       Date:  2017-09       Impact factor: 6.508

5.  Evaluating the Patterns of Aging-Related Tau Astrogliopathy Unravels Novel Insights Into Brain Aging and Neurodegenerative Diseases.

Authors:  Gabor G Kovacs; John L Robinson; Sharon X Xie; Edward B Lee; Murray Grossman; David A Wolk; David J Irwin; Dan Weintraub; Christopher F Kim; Theresa Schuck; Ahmed Yousef; Stephanie T Wagner; Eunran Suh; Vivianna M Van Deerlin; Virginia M-Y Lee; John Q Trojanowski
Journal:  J Neuropathol Exp Neurol       Date:  2017-04-01       Impact factor: 3.685

6.  Pazopanib Reduces Phosphorylated Tau Levels and Alters Astrocytes in a Mouse Model of Tauopathy.

Authors:  Monica Javidnia; Michaeline L Hebron; Yue Xin; Nikolas G Kinney; Charbel E-H Moussa
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

7.  Analysis of isoform-specific tau aggregates suggests a common toxic mechanism involving similar pathological conformations and axonal transport inhibition.

Authors:  Kristine Cox; Benjamin Combs; Brenda Abdelmesih; Gerardo Morfini; Scott T Brady; Nicholas M Kanaan
Journal:  Neurobiol Aging       Date:  2016-07-29       Impact factor: 4.673

8.  Progressive supranuclear palsy and primary lateral sclerosis secondary to globular glial tauopathy: a case report and a practical theoretical framework for the clinical prediction of this rare pathological entity.

Authors:  Andy J Liu; Jessica E Chang; Georges Naasan; Adam L Boxer; Bruce L Miller; Salvatore Spina
Journal:  Neurocase       Date:  2020-02-23       Impact factor: 0.881

Review 9.  Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy.

Authors:  Gabor G Kovacs; Isidro Ferrer; Lea T Grinberg; Irina Alafuzoff; Johannes Attems; Herbert Budka; Nigel J Cairns; John F Crary; Charles Duyckaerts; Bernardino Ghetti; Glenda M Halliday; James W Ironside; Seth Love; Ian R Mackenzie; David G Munoz; Melissa E Murray; Peter T Nelson; Hitoshi Takahashi; John Q Trojanowski; Olaf Ansorge; Thomas Arzberger; Atik Baborie; Thomas G Beach; Kevin F Bieniek; Eileen H Bigio; Istvan Bodi; Brittany N Dugger; Mel Feany; Ellen Gelpi; Stephen M Gentleman; Giorgio Giaccone; Kimmo J Hatanpaa; Richard Heale; Patrick R Hof; Monika Hofer; Tibor Hortobágyi; Kurt Jellinger; Gregory A Jicha; Paul Ince; Julia Kofler; Enikö Kövari; Jillian J Kril; David M Mann; Radoslav Matej; Ann C McKee; Catriona McLean; Ivan Milenkovic; Thomas J Montine; Shigeo Murayama; Edward B Lee; Jasmin Rahimi; Roberta D Rodriguez; Annemieke Rozemüller; Julie A Schneider; Christian Schultz; William Seeley; Danielle Seilhean; Colin Smith; Fabrizio Tagliavini; Masaki Takao; Dietmar Rudolf Thal; Jon B Toledo; Markus Tolnay; Juan C Troncoso; Harry V Vinters; Serge Weis; Stephen B Wharton; Charles L White; Thomas Wisniewski; John M Woulfe; Masahito Yamada; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2015-12-10       Impact factor: 17.088

10.  Brain pathologies in extreme old age.

Authors:  Janna H Neltner; Erin L Abner; Gregory A Jicha; Frederick A Schmitt; Ela Patel; Leonard W Poon; Gearing Marla; Robert C Green; Adam Davey; Mary Ann Johnson; S Michal Jazwinski; Sangkyu Kim; Daron Davis; John L Woodard; Richard J Kryscio; Linda J Van Eldik; Peter T Nelson
Journal:  Neurobiol Aging       Date:  2015-10-19       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.